Infectious Disease Diagnostics Market
Report ID: SQMIG35D2341
Report ID: SQMIG35D2341
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35D2341 |
Region:
Global |
Published Date: December, 2025
Pages:
186
|Tables:
187
|Figures:
79
Global Infectious Disease Diagnostics Market size was valued at USD 22.94 Billion in 2024 and is poised to grow from USD 24.82 Billion in 2025 to USD 46.63 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026–2033).
Surge in prevalence of infectious diseases, advancements in molecular diagnostics, high demand for point-of-care testing, rising awareness regarding infectious diseases, and high adoption of telemedicine are boosting sales of infectious disease diagnostics solutions.
The increasing incidence of infectious diseases such as HIV, tuberculosis, hepatitis, and emerging viral outbreaks like COVID-19 and Zika is primarily driving the global infectious disease diagnostics market growth. Technological advancements in PCR (polymerase chain reaction), next-generation sequencing (NGS), and CRISPR-based diagnostics are fostering innovation in infectious disease diagnostics. High preference for convenience, rapid results, and minimal infrastructure requirements are helping drive the popularity of point-of-care diagnostics. Partnerships between diagnostic companies and digital health firms have further streamlined logistics and reporting. The growth of telehealth services and patient demand for convenience have accelerated the adoption of at-home infectious disease testing.
On the contrary, high costs of advanced diagnostic tools, regulatory challenges, limited infrastructure in developing regions, data privacy and ethical concerns are estimated to limit the global infectious disease diagnostics market penetration through 2032 and beyond.
How AI and Big Data are Transforming Infectious Disease Diagnostics?
Artificial intelligence (AI) and big data analytics are increasingly transforming infectious disease diagnostics by enabling faster, more accurate, and predictive outcomes. AI algorithms assist in identifying infection patterns, optimizing test selection, and interpreting complex diagnostic data such as images, molecular results, and epidemiological information. Machine learning enhances accuracy in differentiating between similar pathogens and helps in outbreak prediction and surveillance. Cloud-based platforms further facilitate data sharing across healthcare systems, aiding real-time decision-making. This convergence of AI and diagnostics supports personalized treatment plans, early interventions, and improved patient outcomes, becoming a critical trend shaping the future of infectious disease management.
Market snapshot - 2026-2033
Global Market Size
USD 22.8 billion
Largest Segment
Reagents, Kits, Consumables
Fastest Growth
Software & Services
Growth Rate
8.3% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global infectious disease diagnostics market is segmented by product, testing type, sample type, disease type, technology, end user and region. Based on product, the market is segmented into reagents, kits, and consumables, instruments, and software & services. Based on testing type, the market is segmented into laboratory testing and POC Testing. Based on sample type, the market is segmented into blood, serum, and plasma, urine and other sample types. Based on disease type, the market is segmented into hepatitis, HIV, hospital-acquired infections, mosquito-borne diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, and other infectious diseases. Based on technology, the market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing, DNA microarray, and other technologies. Based on end user, the market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Which Infectious Disease Diagnostics Product is Slated to Bring in the Most Revenue?
The reagents, kits, and consumables segment is estimated to hold the highest global infectious disease diagnostics market share going forward. Recurring use of kits, reagents, and consumables in all kinds of diagnostic testing procedures is helping this segment maintain its dominance. Growing volume of diagnostic tests performed around the world and bulk procurement of these products by laboratories and hospitals are also helping cement the high share of this segment.
On the other hand, the demand for software & services is expected to rise at a robust pace over the coming years as per this infectious disease diagnostics market forecast. Growing integration of digital technologies in healthcare and diagnostics is helping create new opportunities via this segment. As telemedicine adoption rises and decentralized testing becomes more common, it generates more opportunities for this segment.
Which Sample Type is Used in Most Infectious Disease Diagnostics Solutions?
The blood, serum, and plasma segment is slated to spearhead the global infectious disease diagnostics market revenue generation potential over the coming years. High diagnostic accuracy associated with this type of sample and its high compatibility with most molecular and immunoassay-based platforms are helping it dominance. High reliance of point of care tests and rapid tests on blood samples are also boosting their adoption.
Meanwhile, the use of urine sample for infectious disease diagnostics is slated to rise at a notable pace over the coming years. Rising preference for non-invasive diagnostic testing and emphasis on sexually transmitted infections (STIs) detection are helping this segment generate new opportunities in the long run.
To get detailed segments analysis, Request a Free Sample Report
Why is Adoption of Infectious Disease Diagnostics High in North America?
The presence of an advanced healthcare infrastructure, robust R&D capabilities, and rising diagnostic awareness are expected to help this region lead global infectious disease diagnostics adoption. Widespread adoption of molecular testing and favorable reimbursement policies are also predicted to help cement the dominance of North America over the coming years. The region’s proactive government initiatives and rapid response to disease outbreaks also play a crucial role in strengthening its sway in the global diagnostics innovation and adoption landscape.
Infectious Disease Diagnostics Market in United States
Extensive investments in diagnostics R&D and innovation coupled with high diagnostics awareness makes United States a global leader in infectious disease diagnostics adoption. Presence of an expansive network of diagnostic laboratories, public health programs, and advanced molecular testing capabilities is also helping cement the dominance of this country. Private sector investment and public health funding are expected to sustain strong market growth through 2032 and beyond.
Infectious Disease Diagnostics Market in Canada
Growing adoption of molecular diagnostics and launch of public health campaigns are governing infectious disease diagnostics demand in the country. The Public Health Agency of Canada actively supports disease surveillance and laboratory capacity-building, which ensures sustained adoption of infectious disease diagnostics. The integration of telehealth and digital diagnostics is a popular trend in Canada. Public-private partnerships and favorable regulatory environment drive widespread infectious disease diagnostics innovation.
Why are Infectious Disease Diagnostics Innovators Targeting Asia Pacific?
Surge in incidence of chronic infectious diseases, high population density, and growing healthcare access are positioning Asia Pacific as the most opportune region. Launch of new mass disease surveillance and screening programs across multiple countries is also creating new business scope for infectious disease diagnostics companies. Growth in diagnostic laboratories, public health campaigns, and adoption of point-of-care testing are also driving up the sales of infectious disease diagnostics products.
Infectious Disease Diagnostics Market in Japan
High public health standards and an advanced healthcare infrastructure drive up infectious disease diagnostics demand in Japan. The country experiences recurring challenges from influenza, norovirus, tuberculosis, and drug-resistant infections, creating sustained demand for diagnostics. Japan’s expertise in R&D of molecular and PCR-based technologies is also helping it emerge as a key market in the Asia Pacific. Rising awareness among aging populations and the adoption of digital diagnostics further boost business potential.
Infectious Disease Diagnostics Market in South Korea
Advanced biotech infrastructure and strong government backing for innovation help make South Korea a dynamic market for infectious disease diagnostics companies. Investments in PCR, POC testing, and AI-driven diagnostics are spearheading innovation in the country. Collaborations between public health agencies and private diagnostic firms are also improving accessibility to advanced infectious disease diagnostics. The country’s tech-driven healthcare ecosystem makes it a safe haven for Ai-powered infectious disease diagnostics solutions.
Should Infectious Disease Diagnostics Companies Invest in Europe?
Growing emphasis on early diagnosis of infectious diseases and presence of a well-established healthcare infrastructure steadily influence the sales of infectious disease diagnostics products in Europe. Increasing investments in antimicrobial resistance monitoring and rapid diagnostic tools for indications such as tuberculosis, hepatitis, and HIV are also expected to help boost market development potential. EU-funded R&D programs and public-private partnerships play a crucial role in fostering infectious disease diagnostics innovation.
Infectious Disease Diagnostics Market in United Kingdom
National Health Service (NHS), Public Health England (now UKHSA), and government funding for diagnostic innovation are playing a crucial role in driving infectious disease diagnostics adoption in the country. High investments in genomic surveillance, digital diagnostics, and home-based testing in the United Kingdom is also expected to bolster the sales of infectious disease diagnostics products going forward. Government emphasis on early detection of infectious diseases is also expected to promote the uptake of advanced infectious disease diagnostics solutions.
Infectious Disease Diagnostics Market in Germany
Advanced laboratory networks, strict regulatory oversight, and a developed healthcare infrastructure help Germany emerge as a leader in infectious disease diagnostics adoption in this region. Emphasis on hospital infection control, insurance coverage, and government funding are all helping boost the business scope of infectious disease diagnostics providers operating in Germany. Collaborations between biotech firms and academic institutions are also popular in the country.
Infectious Disease Diagnostics Market in France
Launch of national disease screening programs and backing from public health institutions such as Santé Publique France are governing infectious disease diagnostics demand in the country. Robust investments in molecular and point-of-care diagnostics R&D backed by EU and national funding schemes is also helping France emerge as a key innovator in Europe. The integration of diagnostics into digital health platforms is a growing trend improving access and real-time disease monitoring.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Infectious Disease Diagnostics Market Drivers
Launch of Government and NGO Initiatives for Disease Control
Increasing Awareness Due to Screening Programs
Infectious Disease Diagnostics Market Restraints
Limited Infrastructure in Developing Regions
Data Privacy and Ethical Concerns
Request Free Customization of this report to help us to meet your business objectives.
Infectious disease diagnostics providers should focus on increasing the efficacy of their tests and reduce their result times by investing in R&D. Leveraging advanced technologies such as AI and molecular diagnostics is also a prominent opportunity for companies as per this global infectious disease diagnostics market analysis.
Development of rapid diagnostic test kits is the prime focus of new companies. Here’s a startup that is pioneering novel tests and diagnostics for a variety of infectious diseases.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the growing prevalence of infectious diseases and advancements in infectious disease diagnostics technologies are anticipated to drive the demand for infectious disease diagnostics going forward. However, high costs of advanced diagnostics tools and ethical and privacy concerns are slated to slow down the adoption of infectious disease diagnostics in the future. North America is slated to spearhead the demand for infectious disease diagnostics owing to the presence of a developed healthcare infrastructure and favorable reimbursement policies. The development of at-home testing kits and use of multiplex testing panels are anticipated to be key trends driving the infectious disease diagnostics industry through 2032 and beyond.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 22.94 Billion |
| Market size value in 2033 | USD 46.63 Billion |
| Growth Rate | 8.2% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Infectious Disease Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Infectious Disease Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Infectious Disease Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Infectious Disease Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
